Selective Laser Sintering of Atomoxetine Tablets: An Innovative Approach for Small-Scale, Personalized Production
Pharmaceutics · 18.06.2025 · 17 (6) · 794
DOI: 10.3390/pharmaceutics17060794 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 18.06.2025. Verfasst von Gordana Stanojević und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Medicines and Medical Devices of Montenegro, Ivana Crnojevića 64a, 81000 Podgorica, Montenegro. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science, Technological Development and Innovation, Republic of Serbia.
Abstract (Originalsprache)
Background/Objectives: The growing interest in personalized medicine has accelerated the exploration of three-dimensional (3D) printing technologies in pharmaceutical applications. This study investigates the potential of selective laser sintering (SLS) as a flexible, small-scale manufacturing method for atomoxetine tablets tailored for individualized therapy, comparing it with conventional direct compression.
Methods
Atomoxetine tablets were produced using SLS 3D printing with varying laser scanning speeds and compared to tablets made via a compaction simulator. Formulations were based on hydroxypropyl methylcellulose (HPMC) as the primary matrix former. The physical properties, drug content, disintegration time, and dissolution profiles were evaluated. The structural and chemical integrity were assessed using SEM, FTIR, DSC, and XRPD.
Results
The SLS tablets exhibited comparable mechanical properties and drug content to those made by compaction. Lower laser speeds produced harder tablets with slower disintegration, while higher speeds yielded more porous tablets with ultra-rapid drug release (>85% in 15 min). All tablets met the European Pharmacopoeia dissolution criteria. No significant drug–excipient interactions or changes in crystallinity were detected.
Conclusions
SLS printing is a viable alternative to traditional tablet manufacturing, offering control over drug release profiles through parameter adjustment. The technique supports the development of high-quality, patient-specific dosage forms and shows promise for broader implementation in personalized pharmaceutical therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Medicines and Medical Devices of Montenegro, Ivana Crnojevića 64a, 81000 Podgorica, Montenegro.
- Faculty of Medicine, University of Montenegro, Kruševac bb, 81000 Podgorica, Montenegro.
- Department of Pharmaceutical Technology and Cosmetology, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, 11221 Belgrade, Serbia.
ORCID-Profile: Gordana Stanojević, Ivana Adamov, Veselinka Vukićević, Svetlana Ibrić
Förderung
- Ministry of Science, Technological Development and Innovation, Republic of Serbia
Zitieren
APA
Stanojević, G., Adamov, I., Mugoša, S., Vukićević, V., & Ibrić, S. (2025). Selective Laser Sintering of Atomoxetine Tablets: An Innovative Approach for Small-Scale, Personalized Production. Pharmaceutics, 17(6), 794. https://doi.org/10.3390/pharmaceutics17060794
Vancouver
Stanojević G, Adamov I, Mugoša S, Vukićević V, Ibrić S. Selective Laser Sintering of Atomoxetine Tablets: An Innovative Approach for Small-Scale, Personalized Production. Pharmaceutics. 2025;17(6):794. doi:10.3390/pharmaceutics17060794
BibTeX
@article{Stanojevi2025,
author = {Stanojević, Gordana and Adamov, Ivana and Mugoša, Snežana and Vukićević, Veselinka and Ibrić, Svetlana},
title = {Selective Laser Sintering of Atomoxetine Tablets: An Innovative Approach for Small-Scale, Personalized Production},
journal = {Pharmaceutics},
year = {2025},
volume = {17},
number = {6},
pages = {794},
doi = {10.3390/pharmaceutics17060794}
}
EUVIMED